Chen D, Fong H W, Davis J S
The Women's Research Institute, Department of Obstetrics and Gynecology, University of Kansas School of Medicine-Wichita, Kansas 67214, USA.
Endocrinology. 2001 Feb;142(2):887-95. doi: 10.1210/endo.142.2.7938.
PGF2alpha triggers the demise of the corpus luteum whereby progesterone synthesis is inhibited, the luteal structure regresses, and the estrus cycle resumes. Upon binding to its heterotrimeric G-protein-coupled receptors, PGF2alpha initiates the phospholipase C/diacylglycerol and inositol-1,4,5-trisphosphate/Ca(2+)-protein kinase C (PKC) signaling pathway. More recently, we have demonstrated that PGF2alpha activates extracellular signal-regulated kinase (ERK) mitogen-activated protein (MAP) kinase signaling through a Raf-dependent mechanism in bovine luteal cells. However, the relationship between PKC and ERK activation in PGF2alpha signaling has not been clearly defined. Moreover, the signaling pathway that PGF2alpha uses to regulate gene expression is unknown. In this report, primary cultures of bovine luteal cells were used to address the role of PKC in ERK activation and the signaling pathway for induction of c-fos and c-jun messenger RNA (mRNA) expression in response to PGF2alpha. By using a PKC inhibitor and a PKC-deficient luteal cell model, we observed that phorbol ester-responsive isoforms of PKC were required for ERK phosphorylation and activation by PGF2alpha (1 microM) or phorbol 12-myristate 13-acetate (PMA) (20 nM). In PGF2alpha- and PMA-treated cells, active ERK MAP kinase was localized in the nucleus. PGF2alpha-induced ERK phosphorylation was dose-dependently inhibited by the MEK1 inhibitor PD098059 (1-50 microM). The expression of c-fos and c-jun mRNA in luteal cells was markedly increased by treatment with PGF2alpha (1 microM) or PMA (20 nM) for 30 min. We also observed that activation of ERK MAP kinase was required for the expression of c-fos and c-jun mRNA in response to PGF2alpha and PMA because it was abrogated by blocking the ERK pathway with PD098059. In addition, PGF2alpha and PMA-induced c-fos and c-jun mRNA expression was abolished in the PKC-deficient cells. Taken together, our data demonstrate that a PKC-dependent ERK MAP kinase pathway mediates the expression of c-fos and c-jun mRNA in PGF2alpha-treated bovine luteal cells.
前列腺素F2α(PGF2α)引发黄体退化,从而抑制孕酮合成,黄体结构退化,发情周期恢复。PGF2α与其异源三聚体G蛋白偶联受体结合后,启动磷脂酶C/二酰甘油和肌醇-1,4,5-三磷酸/Ca(2+)-蛋白激酶C(PKC)信号通路。最近,我们证明PGF2α通过一种依赖Raf的机制在牛黄体细胞中激活细胞外信号调节激酶(ERK)丝裂原活化蛋白(MAP)激酶信号通路。然而,PGF2α信号通路中PKC与ERK激活之间的关系尚未明确界定。此外,PGF2α用于调节基因表达的信号通路也不清楚。在本报告中,利用牛黄体细胞原代培养来探讨PKC在ERK激活中的作用以及PGF2α诱导c-fos和c-jun信使核糖核酸(mRNA)表达的信号通路。通过使用PKC抑制剂和PKC缺陷黄体细胞模型,我们观察到PGF2α(1微摩尔)或佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)(20纳摩尔)诱导ERK磷酸化和激活需要PKC的佛波酯反应性亚型。在PGF2α和PMA处理的细胞中,活性ERK MAP激酶定位于细胞核。MEK1抑制剂PD098059(1 - 50微摩尔)剂量依赖性地抑制PGF2α诱导的ERK磷酸化。用PGF2α(1微摩尔)或PMA(20纳摩尔)处理30分钟后,黄体细胞中c-fos和c-jun mRNA的表达显著增加。我们还观察到,由于用PD098059阻断ERK通路可消除这种作用,因此PGF2α和PMA诱导c-fos和c-jun mRNA表达需要ERK MAP激酶的激活。此外,在PKC缺陷细胞中,PGF2α和PMA诱导的c-fos和c-jun mRNA表达被消除。综上所述,我们的数据表明,PKC依赖性ERK MAP激酶通路介导PGF2α处理的牛黄体细胞中c-fos和c-jun mRNA的表达。